References
- Johnson KJ, Hussain I, Williams K, Santens R, Mueller NL, Gutmann DH.Development of an international internet-based neurofibromatosis Type 1 patient registry. Contemp Clin Trials. 2013;34(2):305–11.doi:https://doi.org/10.1016/j.cct.2012.12.002.
- Anderson JL, Gutmann DH.Neurofibromatosis type 1. Handb Clin Neurol. 2015;132:75–86.
- Prada CE, Rangwala FA, Martin LJ, Lovell AM, Saal HM, Schorry EK, Hopkin RJ . Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1. J Pediatr. 2012;160(3):461–67.doi:https://doi.org/10.1016/j.jpeds.2011.08.051.
- Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D.The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol. 2014;67(1):46–51.doi:https://doi.org/10.1016/j.jclinepi.2013.08.003.
- Plotkin SR, Wick A.Neurofibromatosis and Schwannomatosis. Semin Neurol. 2018;38(1):73–85.doi:https://doi.org/10.1055/s-0038-1627471.
- Tomei KL, Gupta V, Prestigiacomo CJ, Gandhi CD.Spontaneous hemorrhage of a facial neurofibroma: endovascular embolization before surgical intervention. J Craniofac Surg. 2013;24(5):e514–7.doi:https://doi.org/10.1097/SCS.0b013e3182a23535.
- Walker JA, Upadhyaya M.Emerging therapeutic targets for neurofibromatosis type 1. Expert Opin Ther Targets. 2018;22(5):419–37.doi:https://doi.org/10.1080/14728222.2018.1465931.
- Jouhilahti EM, Peltonen S, Heape AM, Peltonen J.The pathoetiology of neurofibromatosis 1. Am J Pathol. 2011;178(5):1932–39.doi:https://doi.org/10.1016/j.ajpath.2010.12.056.
- Tung TC, Chen YR, Chen KT, Chen CT, Bendor-Samuel R.Massive intratumor hemorrhage in facial plexiform neurofibroma. Head Neck. 1997;19(2):158–62.doi:https://doi.org/10.1002/(SICI)1097-0347(199703)19:2<158::AID-HED13>3.0.CO;2-9.
- Yunoki M, Hiramatsu M, Hirashita K, Gohda Y, Yoshino K, Fujimoto S, Tanaka H, Mizobuchi K, Takata K, Morito T, et al. A case of neurofibromatosis-1 in which severe bleeding was observed from a neurofibroma under the scalp. No Shinkei Geka 2010;38:265–72.
- Feng Y, Yang ZG, Chen T, Wang Q, Deng W.Giant plexiform neurofibroma with hemorrhage in cranio-maxillofacial region as depicted on CT and MRI. Eur J Med Res. 2010;15(2):84–87.doi:https://doi.org/10.1186/2047-783X-15-2-84.
- Sun ZJ, Zhao YF, Wang SP, He SG.Giant facial haematoma in neurofibromatosis type 1. Dentomaxillofac Radiol. 2008;37(1):52–57.doi:https://doi.org/10.1259/dmfr/89572785.
- Smith TP.Embolization in the external carotid artery. J Vascular and Interventional Radiol. 2006;17(12):1897–912; quiz 913.doi:https://doi.org/10.1097/01.RVI.0000247301.64269.27.
- Sadri M, Midwinter K, Ahmed A, Parker A.Assessment of safety and efficacy of arterial embolisation in the management of intractable epistaxis. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology. Head Neck Surg. 2006;263(6):560–66.
- Grandhi R, Panczykowski D, Zwagerman NT, Gehris R, Villasenor-Park J, Ho J, Grandinetti, L, Horowitz, M . Facial necrosis after endovascular Onyx-18 embolization for epistaxis. Surg Neurol Int. 2013;4(1):95.doi:https://doi.org/10.4103/2152-7806.115388.
- Ntomouchtsis A, Venetis G, Zouloumis L, Lazaridis N.Ischemic necrosis of nose and palate after embolization for epistaxis. A case report. Oral Maxillofac Surg. 2010;14(2):123–27.doi:https://doi.org/10.1007/s10006-009-0190-4.
- Kehrer-Sawatzki H, Farschtschi S, Mautner VF, Cooper DN.The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis. Hum Genet. 2017;136(2):129–48.doi:https://doi.org/10.1007/s00439-016-1753-8.
- Blakeley JO, Plotkin SR.Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro-oncology. 2016;18(5):624–38.doi:https://doi.org/10.1093/neuonc/nov200.
- Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A.Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 2002;39(5):311–14.doi:https://doi.org/10.1136/jmg.39.5.311.
- Dombi E, Solomon J, Gillespie AJ, Fox E, Balis FM, Patronas N, Korf BR, Babovic-Vuksanovic D, Packer RJ, Belasco J, et al. NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology. 2007;68(9):643–47.doi:https://doi.org/10.1212/01.wnl.0000250332.89420.e6.
- Sørensen SA, Mulvihill JJ, Nielsen A.Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986;314(16):1010–15.doi:https://doi.org/10.1056/NEJM198604173141603.
- Zöller M, Rembeck B, Akesson HO, Angervall L.Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden. Acta Derm Venereol. 1995;75(2):136–40.doi:https://doi.org/10.2340/0001555575136140.
- Evans DG, O’Hara C, Wilding A, Ingham SL, Howard E, Dawson J, Moran A, Scott-Kitching V, Holt F, Huson SM, et al. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. European J Human Genet. 2011;19(11):1187–91.doi:https://doi.org/10.1038/ejhg.2011.113.
- Rasmussen SA, Yang Q, Friedman JM.Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. 2001;68(5):1110–18.doi:https://doi.org/10.1086/320121.
- Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44(2):81–88.doi:https://doi.org/10.1136/jmg.2006.045906.
- Fleming AJ, Chi SN.Brain tumors in children. Current problems in pediatric and adolescent health care. Current Problems in Pediatric and Adolescent Health Care. 2012;42(4):80–103.doi:https://doi.org/10.1016/j.cppeds.2011.12.002.
- Huson SM, Harper PS, COMPSTON DAS.Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain: a J Neurology. 1988;111(Pt 6):1355–81.doi:https://doi.org/10.1093/brain/111.6.1355.
- Huttner AJ, Kieran MW, Yao X, Cruz L, Ladner J, Quayle K, Goumnerova, LC, Irons, MB, Ullrich, NJ . Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1. Pediatr Blood Cancer 2010;54:890–96.